Whalegun
Home

Biomarin Pharmaceutical BMRN spent $270K on lobbying in Q2 2025 · Health Issues, Medicare and 2 more issues

Trade details

Type
Lobbying report
Amount
$270,000
Quarter
Q2 2025
Stock
Biomarin Pharmaceutical BMRN
Client
Biomarin Pharmaceutical
Reported
25/07/21

Down 30.8% from last quarter

What else happened in Biomarin Pharmaceutical around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

Biomarin Pharmaceutical's other lobbying reports

Biomarin Pharmaceutical BMRN spent $270K on lobbying in Q2 2025 · Health Issues, Medicare and 2 more issues | Whalegun